SIGN IN
Summer Intern - Trade & Distribution jobs in United States
cer-icon
Apply on Employer Site
company-logo

Harmony Biosciences · 2 days ago

Summer Intern - Trade & Distribution

Harmony Biosciences specializes in developing treatments for rare neurological diseases. The summer internship will support the Market Access team focusing on Trade & Distribution and Patient Services, providing hands-on exposure to specialty pharmaceuticals and their impact on patient access and outcomes.
BiopharmaBiotechnologyHealth Care

Responsibilities

Support Trade and Patient Services initiatives focused on improving patient onboarding, access, and ongoing therapy management
Assist with the analysis of specialty pharmacy performance metrics (e.g., referral volume, conversion, time-to-fill, adherence)
Help analyze patient access trends and identify opportunities to improve patient experience
Support coordination between Patient Services and Trade teams to ensure alignment on access strategies

Qualification

ExcelPowerPointTeamsCommunication skillsInterpersonal skills

Required

Minimum age for all candidates must be at least 18 years or older
Must be enrolled in an accredited college or university as a rising sophomore, junior, or senior pursuing a degree in Pharmacy
Must be proficient in the use of MS Excel, MS PowerPoint, and MS Teams
Demonstrated interpersonal skills, including flexibility, collaboration, and inclusion skills, and the ability to work in a team environment
Candidates must have strong written and verbal communication skills

Preferred

Prior work experience required
Strong communication skills (written, verbal, and presentation)

Company

Harmony Biosciences

twittertwittertwitter
company-logo
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Funding

Current Stage
Public Company
Total Funding
$1.68B
Key Investors
Blackstone Life SciencesBlackstone GroupOrbiMed
2024-10-30Post Ipo Secondary· $248M
2023-07-27Post Ipo Debt· $185M
2021-11-01Post Ipo Equity· $200M

Leadership Team

leader-logo
Jeffrey M. Dayno
President & Chief Executive Officer
linkedin
leader-logo
Jeffrey Dierks
EVP & Chief Commercial Officer
linkedin
Company data provided by crunchbase